ABT
Abbott Laboratories
Abbott Laboratories is a diversified global medical device, diagnostics, nutrition, and pharmaceutical company whose political exposure centers on FDA regulation, Medicare/Medicaid reimbursement, and healthcare policy.
Govt Dependence
55/100
Regulatory Density
78/100
Lobbying Intensity
35/100
Political Signal
MEDIUM
BusinessWhat ABT does
Abbott develops and sells medical devices (cardiovascular, diabetes care/continuous glucose monitors), diagnostics, branded generic pharmaceuticals, and nutrition products (Similac, Ensure). Revenue is diversified across these four segments with significant international exposure.
12 months past · 3 months futureABT activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
167 trading days ·
27 congressional trades shown
·
2 insider buys
·
10 13F filings
·
1 past bill actions
·
3 upcoming markups
Executive Branch ConflictsABT held by Trump-administration officials
2 cabinet/senior officials reported ABT positions in OGE Form 278 disclosures across 10 filings.
Donald J. Trump
President · White House
ABBOTT LABORATORIES
Donald J. Trump
President · White House
ABBOTT LABORATORIES
Donald J. Trump
President · White House
ABBOTT LABORATORIES
Donald J. Trump
President · White House
Abbott Laboratories
Donald J. Trump
President · White House
ABBOTT LABS
Donald J. Trump
President · White House
ABBOTT LABORATORIES
Donald J. Trump
President · White House
Abbott Labs
Donald J. Trump
President · White House
Abbott Laboratories
Donald J. Trump
President · White House
Abbott Laboratories
Jamieson Greer
U.S. Trade Representative · Office of the USTR
Abbott Laboratories
Lifetime Government AwardsABT federal contracts by year
$132M
total awarded · 2000–2013
1000
contracts on file
2013
peak year ($55M)
Top contracts by award amount
$8.6M
Department of Veterans Affairs
2013-10-01
INTEGRATED CHEMISTRY AND IMMUNOASSAY TESTING ANALYZERS
$6.5M
Department of Veterans Affairs
2013-10-01
IGF::OT::IGF - COST PER REPORTABLE TEST
$5.1M
Department of Veterans Affairs
2013-07-01
MODIFICATION TO ADD ADDITIONAL TESTING AND PRICING.
$2.9M
Department of Veterans Affairs
2012-10-01
CHEMISTRY - LABORATORY FOR VISN 15 FUNDING FOR REST OF BASE YEAR 01 OC
$2.9M
Department of Veterans Affairs
2011-10-03
PROVIDE HEMOTOLOGY SERVICES TO ALL VISN 15 STATIONS BY ABBOTT
14 years · 1000 contracts
Smart Money · 13F HoldingsHedge funds holding ABT
$788.36B
Total ABT held by tracked 13F funds
7
Funds with ABT positions
+2
Funds opened this quarter
Two Sigma Investments
$655.94B
opened
12 overlap
2026-03-31
Renaissance Technologies
$127.17B
+122%
12 overlap
2026-03-31
Soros Fund Management
$4.59B
opened
12 overlap
2026-03-31
Citadel Advisors
$308M
+31%
17 overlap
2025-12-31
D.E. Shaw & Co.
$169M
+159%
17 overlap
2025-12-31
Millennium Management
$155M
+76%
2025-12-31
Bridgewater Associates
$15M
holds
17 overlap
2025-12-31
Politicians Trading ABTMembers of Congress with recent ABT positions
20 politicians traded ABT across 104 disclosed transactions totaling $1.8M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ABT). 0-30 LOW · 30-60 MID · 60+ HIGH.
Michael T. McCaul
8 buys
9 sells
$819K
2026-03-04
LOW · 0
Ro Khanna
7 buys
16 sells
$307K
2026-06-02
LOW · 0
Jefferson Shreve
2 sells
$150K
2025-05-12
LOW · 0
Josh Gottheimer
10 buys
5 sells
$120K
2026-05-27
LOW · 1
Markwayne Mullin
4 sells
$81K
2025-01-08
LOW · 29
Thomas H. Kean
5 buys
$40K
2026-01-29
LOW · 2
Gilbert Ray Cisneros
2 buys
3 sells
$40K
2026-06-16
HIGH · 61
Julie Johnson
5 sells
$40K
2026-05-12
LOW · 15
Rick W. Allen
1 sell
$33K
2026-04-16
LOW · 2
Bruce Westerman
2 buys
2 sells
$32K
2025-04-21
LOW · 0
Lisa C. McClain
2 buys
2 sells
$32K
2025-07-10
LOW · 0
Rick Larsen
2 buys
1 sell
$24K
2026-07-08
LOW · 2
Byron Donalds
2 buys
1 sell
$24K
2025-12-04
LOW · 1
John James
2 sells
$16K
2024-09-04
LOW · 0
Julia Letlow
1 buy
1 sell
$16K
2025-12-08
LOW · 1
5 more politicians active in ABT · full table in member dashboard
Congressional TradesWho in Congress is trading ABT
2026-07-08
Rick Larsen
Sale
$1,001 - $15,000
2026-06-02
Ro Khanna
Purchase
$1,001 - $15,000
2026-06-16
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2026-05-12
Julie Johnson
Sale
$1,001 - $15,000
2026-05-15
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-04-16
Rick W. Allen
Sale
$15,001 - $50,000
2026-05-27
Josh Gottheimer
Sale
$1,001 - $15,000
2026-03-24
Laura Friedman
Exchange
$1,001 - $15,000
2026-03-04
Michael T. McCaul
Sale
$1,001 - $15,000
2026-03-19
Richard McCormick
Purchase
$1,001 - $15,000
2026-02-10
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-01-29
Thomas H. Kean
Purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-07-13
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Open-market buys
A
Insider signal score 55/100 · 2 distinct insiders · 5 open-market buys totaling $2.7M in the last 180 days.
2026-02-04
STARKS DANIEL J
BUY
5,033 sh
$545K
Stock awards & option exercises
38
stock awards · $172.2M market value
2026-03-31
Stratton John G
Director
AWARD
382 sh
$39K
2026-03-31
Roman Michael F
Director
AWARD
367 sh
$38K
2026-03-31
Gonzalez Patricia Paola
Director
AWARD
321 sh
$33K
2026-03-31
Ahuja Nita
Director
AWARD
102 sh
$10K
2026-03-31
Alpern Robert J
Director
AWARD
76 sh
$8K
2026-03-23
ORVILLE JACOB A
Senior Vice President
AWARD
13,255 sh
$1.4M
2026-03-23
ORVILLE JACOB A
Senior Vice President
AWARD
13,255 sh
$1.4M
2026-03-23
ORVILLE JACOB A
Senior Vice President
AWARD
13,255 sh
$1.4M
For ABT, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.
Bills Affecting ABTLive legislation impacting this stock
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.1875 · 119th
Medicaid Provider Screening Accountability Act
HR.1867 · 119th
To amend title XVIII of the Social Security Act to remove in-person requirements under Medicare for mental health services furnish
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HRES.185 · 119th
Recognizing the need of Congress to prevent, address, and treat obesity as a disease in the United States on this World Obesity Da
HRES.182 · 119th
Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".
S.786 · 119th
Public Health Funding Restoration Act
S.763 · 119th
Telehealth Expansion Act of 2025
HR.679 · 119th
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strate
S.574 · 118th
Increasing Prescription Drug Competition Act
Political ProfileWhere ABT sits in Washington
bipartisan
Abbott moves on FDA device decisions, Medicare/Medicaid reimbursement changes, and formula-safety headlines, but its diversification dampens sensitivity to any single policy event.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA device regulation and recalls
- Medicaid drug price transparency
- infant formula/FDA safety scrutiny
- IVD/LDT diagnostic regulation
- tariffs on medical imports
Regulatory opportunities
- expanded CGM/diabetes device Medicare coverage
- telehealth expansion
- diagnostic reimbursement expansion
- mental health access funding
LobbyingWho's hired to advocate for ABT
AdvaMedPhRMAMITAAmerican Clinical Laboratory Association
Member intelligence layer
Live signals + predictions for ABT — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades ABT
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout ABT & political exposure
Does Abbott Laboratories (ABT) hold federal contracts?
Yes. Abbott Laboratories has 5879 federal contract awards totaling $1,196,473,143, primarily from agencies including Department of Agriculture, Department of Commerce, Department of Defense. See full contract list and amounts on this page.
Which Trump cabinet officials own ABT stock?
2 Trump cabinet members or senior White House staff have disclosed holdings in ABT on their OGE 278 financial disclosures, including Donald J. Trump, Jamieson Greer. See the Cabinet Conflicts panel for details.
Has Congress traded ABT stock?
518 congressional trades by 53 unique members of Congress, most recently on 2026-07-08. See the Congressional Trading panel for politician-by-politician breakdown.
What is ABT political risk profile?
Government dependence: 55/100. Lobbying intensity: 35/100. Political signal: medium. Donor party split: bipartisan.
How does GovGreed track ABT political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ABT data is updated daily from these official federal sources.